4 Analysts Have This To Say About Revvity
During the last three months, 4 analysts shared their evaluations of Revvity (NYSE:RVTY), revealing diverse outlooks from bullish…
US Stocks Kick Off The Week In The Green, Tesla Rockets On China’s FSD Approval, Yen Rallies: What’s Driving Markets Monday?
U.S. stocks kicked off the week on a positive note, with all major averages edging higher in anticipation of significant events including earnings reports from tech giants like Amazon.com Inc. (NASDAQ:AMZN) on Tuesday and Apple Inc.
Enphase Energy Reports Weak Results, Joins Lithia Motors And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining over 70 points on Wednesday. Shares…
Revvity Signals Software Unveils Signals Clinical Solution To Accelerate Critical Clinical Trial Insights And Data-Driven Decisions
- Centralized data science platform streamlines clinical study data management for swift, insight-driven clinical decisions and therapeutic advancements
- Seamless integration with Spotfire® for
Earnings Scheduled For February 1, 2024
Companies Reporting Before The Bell
• ING Groep (NYSE:ING) is expected to report earnings for its fourth quarter.
• Shell (NYSE:SHEL) is likely to report quarterly earnings at $1.81 per share on revenue of $75.66 billion.
Earnings Preview For Revvity
Revvity (NYSE:RVTY) is set to give its latest quarterly earnings report on Thursday, 2024-02-01. Here’s what investors need…
The Latest Analyst Ratings For Revvity
Ratings for Revvity (NYSE:RVTY) were provided by 7 analysts in the past three months, showcasing a mix of…
Peeling Back The Layers: Exploring Revvity Through Analyst Insights
Throughout the last three months, 7 analysts have evaluated Revvity (NYSE:RVTY), offering a diverse set of opinions from…
7 Analysts Have This to Say About Revvity
Analysts have provided the following ratings for Revvity (NYSE:RVTY) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…
Why ON Semiconductor Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Gainers
Miromatrix Medical Inc. (NASDAQ: MIRO) shares climbed 230.7% to $3.3401 after United Therapeutics agreed to acquire the company for $3.25 per share in cash.